🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 16/03/2009 | 10,82 | 11,12 | 10,67 | 10,78 | +1,41% | 4,15% | 82.581 |
| 13/03/2009 | 10,70 | 10,85 | 10,52 | 10,63 | -1,05% | 3,15% | 250.175 |
| 12/03/2009 | 10,44 | 10,93 | 10,41 | 10,74 | +1,77% | 5,02% | 517.128 |
| 11/03/2009 | 10,93 | 11,30 | 10,14 | 10,56 | -2,76% | 10,62% | 185.307 |
| 10/03/2009 | 10,63 | 11,04 | 10,33 | 10,85 | +4,32% | 6,69% | 179.776 |
| 09/03/2009 | 10,14 | 10,74 | 9,92 | 10,41 | +0,73% | 8,12% | 82.795 |
| 06/03/2009 | 10,14 | 10,56 | 9,96 | 10,33 | +3,76% | 5,90% | 111.302 |
| 05/03/2009 | 10,33 | 10,89 | 9,92 | 9,96 | -6,99% | 9,42% | 123.137 |
| 04/03/2009 | 11,04 | 11,15 | 10,29 | 10,70 | -1,04% | 7,80% | 174.406 |
| 03/03/2009 | 10,63 | 11,04 | 10,48 | 10,82 | +2,48% | 5,28% | 645.261 |
| 02/03/2009 | 9,96 | 11,23 | 9,88 | 10,56 | +4,06% | 13,53% | 385.949 |
| 27/02/2009 | 9,62 | 10,26 | 9,54 | 10,14 | +2,65% | 7,39% | 162.731 |
| 26/02/2009 | 10,03 | 10,59 | 9,66 | 9,88 | +0,00% | 9,33% | 108.309 |
| 25/02/2009 | 10,52 | 10,67 | 9,88 | 9,88 | -6,71% | 7,47% | 247.049 |
| 24/02/2009 | 9,81 | 10,67 | 9,58 | 10,59 | +9,69% | 11,07% | 165.056 |
| 23/02/2009 | 9,69 | 10,07 | 9,51 | 9,66 | -1,53% | 5,79% | 118.782 |
| 20/02/2009 | 9,58 | 10,11 | 9,58 | 9,81 | +0,38% | 5,47% | 143.682 |
| 19/02/2009 | 10,03 | 10,07 | 9,69 | 9,77 | -1,14% | 3,73% | 92.066 |
| 18/02/2009 | 9,99 | 10,07 | 9,43 | 9,88 | +2,33% | 6,37% | 99.119 |
| 17/02/2009 | 9,54 | 10,07 | 9,36 | 9,66 | -4,09% | 7,45% | 647.906 |
| 13/02/2009 | 10,18 | 10,18 | 9,73 | 10,07 | +0,00% | 4,41% | 166.098 |
| 12/02/2009 | 9,43 | 10,11 | 9,28 | 10,07 | +5,49% | 8,73% | 171.174 |
| 11/02/2009 | 9,36 | 9,73 | 9,17 | 9,54 | +2,41% | 6,00% | 44.189 |
| 10/02/2009 | 9,62 | 9,73 | 9,02 | 9,32 | -4,23% | 7,39% | 80.097 |
| 09/02/2009 | 9,43 | 9,73 | 9,39 | 9,73 | +2,36% | 3,57% | 45.445 |
| 06/02/2009 | 9,51 | 9,73 | 9,10 | 9,51 | -0,39% | 6,69% | 73.097 |
| 05/02/2009 | 8,95 | 9,66 | 8,80 | 9,54 | +5,37% | 9,62% | 69.437 |
| 04/02/2009 | 9,13 | 9,43 | 8,87 | 9,06 | -1,22% | 6,15% | 105.691 |
| 03/02/2009 | 8,95 | 9,25 | 8,80 | 9,17 | +3,38% | 5,02% | 90.302 |
| 02/02/2009 | 8,50 | 8,91 | 8,08 | 8,87 | +11,79% | 9,69% | 258.911 |